Virtual Library
Start Your Search
J.M. Gunn
Author of
-
+
P1.08 - Poster Session with Presenters Present (ID 460)
- Event: WCLC 2016
- Type: Poster Presenters Present
- Track: Surgery
- Presentations: 1
- Moderators:
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.08-028 - Nationwide Trends in Surgery for Lung Cancer in Finland from 2004 to 2014 (ID 4143)
14:30 - 14:30 | Author(s): J.M. Gunn
- Abstract
Background:
Surgical treatment for lung cancer has developed in recent decades and has enabled surgical treatment of patients with increasingly severe comorbidities. The aim of this study is to describe nationwide trends in lung surgery: incidence of surgical treatment, operative mortality, changes in surgical approaches, long term survival and predictors thereof in Finland between 2004 and 2014.
Methods:
Patients with any type of lung surgery and pre- or postoperative diagnosis of C34.* were identified from the national Care Register for Health Care which collects discharge data on all patients discharged from inpatient care as well as outpatients treated in specialized care. Patients were verified as lung cancer patients by linking data with diagnoses from the Finnish Cancer Registry. Mortality data were linked from Statistics Finland.
Results:
During the study period 3912 patients underwent lung surgery for cancer. Mean age was 66 years (SD 9.6), 62% were males. The number of operations increased over the years (p=0.02). Extent of surgery was pneumonectomy in 10%, lobectomy in 79.8% and sublobar resection in 10.2%. Women underwent sublobar resection more often than men (8.2% vs 13.5%, p<0.001). Overall 1 year survival was 85.5% and 5 -year survival was 51.4%. Age, stage of cancer, Charlson comorbidity index (CCI) and the proportion of lobectomy increased during the study period while survival remained stable.Predictors of mortality on multivariable regression were age, male gender, stage, CCI, pneumonectomy and adjuvant therapy.
Conclusion:
Despite a growing number of patients with increasing comorbidities treated surgically in a country with declining incidence of lung cancer and despite more advanced disease postoperative mortality for surgically resected lung cancer has remained stable. This suggests that modern surgical treatment could be offered more confidently to more patients with heavier disease burden.
